Browse studies
Find your next paid study
64 recruiting studies matching your filters
Phase 2
A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer
This phase II trial studies how well giving zanidatamab before surgery (neoadjuvant) works in treating patients with colon and rectal cancer that is human epid…
Colon CarcinomaColorectal CarcinomaRectal Carcinoma+9 more
Estimated
~$10 – $6,250
Emory UniversityNCT07405476
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
Colorectal cancer is the third most common malignancy worldwide, and prognosis largely depends on how effectively metastatic disease is managed. The liver is t…
Colorectal Cancer Liver Metastases (CRLM)Metastatic Colorectal Carcinoma (mCRC)
Estimated
~$10 – $750
City of Hope Medical CenterNCT07224724
Phase 1
A Phase I, Open-label, Non-randomised, Multi-center Dose Escalation Trial of BI 765049 Administered by Parenteral Route in Patients With Advanced, Unresectable, and/or Metastatic Colorectal Carcinoma (CRC), Gastric Carcinoma (GC), or Pancreatic Ductal Adenocarcinoma (PDAC) to Determine the MTD and the RP2D and to Determine the Dosing Regimen for Further Development of BI 765049
This study is open to adults with advanced cancer of the colon, rectum, stomach, or pancreas, that is the cancer cannot be removed by surgery or has spread. Pe…
Colorectal CarcinomaGastric CarcinomaPancreatic Ductal Adenocarcinoma
Estimated
~$10 – $7,500
Boehringer IngelheimNCT06882746
Observational
Evaluation of Treatment Response of Colorectal Cancer Liver Metastases With Intravoxel Incoherent Motion Diffusion Weighted Imaging
This trial evaluates the treatment response of colorectal cancer that has spread to the liver (liver metastases) using intravoxel incoherent motion diffusion w…
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+4 more
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT04796818